1Autism and Developmental Disabilities Monitoring Network. Prevalence of autism spectrum disorders-Autism and Developmental Disabilities Monitoring Network, 14 Sites, United States, 2008[J]. MMWR Surveill Summ, 2012, 61(3): 1-19.
2Kuboa T, Takae H, Miyake K. Epigenetic mechanisms and therapeutic perspectives for neurodevelopmental disorders[J]. Pharmaceuticals (Basel), 2012, 5(4): 369-383.
3Sylvie T, Eszter S, Nathalie C. Genexenvironment interactions in autism spectrum disorders: role of epigenetic mechanisms[J]. Front Psychiatry, 2014, 5(53): 1-17.
4Kim YS, Leventhal BL. Genetic epidemiology and insights into interactive genetic and environmental effects in autism specrum disorders[J]. Biol Psychiatry, 2015, 77(1): 66-74.
5State MW, Levitt P. The conundrums of understanding genetic risks for autism spectrum disorders[J]. Nat Neurosci, 2011, 14(12): 1499-506.
6Hines EP, Calafat AM, Silva MJ, et al. Concentrations of phthalate metabolites in milk, urine, saliva, and serum of lactating North Carolina women[J]. Environ Health Perspect, 2009, 117(1): 86-92.
7Whyatt RM, Liu X, Rauh VA, et al. Maternal prenatal urinary phthalate metabolite concentrations and child mental, psychomotor and behavioral development at age three years[J]. Environ Health Perspect, 2011, 120(2): 290-295.
8Knopik VS. Maternal smoking during pregnancy and child outcomes: real or spurious effect?[J]. Dev Neuropsychol, 2009, 34(1): 1-36.
9Lyall K, Pauls DL, Spieqelman D, et al. Pregnancy complications and obstetric suboptimality in association with autism spectrum disorders in children of the Nurses' Health Study II[J]. Autism Res, 2012, 5(1): 21-30.
10Atlad6ttir HO, Thorsen P, Ostergaard L, et al. Maternal infection requiring hospitalization during pregnancy and autism spectrum disorders[J]. J Autism Dev Disord, 2010, 40(12): 1423-1430.
